News for Minerva Neurosciences, Inc. (NERV)

BURLINGTON, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. ( NERV), a clinical-stage biopharmaceutical company focused on the developmen

**media[456687]**

Minerva shares price target cut, holds rating on FDA concerns

Roche (OTC: RHHBY) announced that the European Commission has granted marketing authorization to the subcutaneous formulation of relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) drug Ocrevus (ocrelizumab).

Cutera appoints new board member with financial expertise

Candel Therapeutics, Inc.

Minerva Neurosciences (NERV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BURLINGTON, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the...

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 100 points on Tuesday. The Dow traded down 0.35% to 38,932.26 while the NASDAQ rose 0.28% to 16,021.41. The S&P 500 also rose, gaining, 0.04% to 5,071.40.

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

Minerva Neurosciences (NERV) stock falls as the FDA rejects its schizophrenia drug candidate, roluperidone. Read more here.

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.10%

U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday.

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Anti-anxiety drugs are medications that are used to treat anxiety disorders that are mainly used to...

The second half of August was tough for the markets but some biotech stocks seemed to have avoided the pain.

Read Analysts’ New Coverage for May 29th (AACG, AAME, ABEO, ACOR, ACRX, ACU, AEMD, AEY, AEZS, AGFS) at ETF Daily News

Read Stock Analysts’ Upgrades for May 28th (AMSC, ARW, BKE, CACI, COTY, HLF, JBSS, LOCL, LXRX, MGEE) at ETF Daily News

Read Research Analysts’ Upgrades for May 21st (ATKR, BKEP, CPF, DK, GWRS, INTT, KVHI, KZIA, LAW, LEGN) at ETF Daily News

Read Investment Analysts’ New Coverage for May 21st (AACG, AAME, ABEO, ACOR, ACRX, ACU, AEMD, AEY, AEZS, AGFS) at ETF Daily News